Arterial structural changes in rats immunized by AT1-receptor peptide
Tóm tắt
Accumulating evidence suggests that anti-AT1 (angiotensin II receptor type 1) receptor antibodies are involved in the pathogenesis of hypertension. We assessed the hypothesis that changes in vascular structure could be induced in rats immunized with AT1-receptor peptide. In this study, an animal model was made by immunizing Wistar rats aged 4 weeks with the synthetic peptide corresponding to the second extracelluar peptide of human AT1 as the antigen and raising them for 1 year, while monitoring their blood pressure, heart rate, and anti-AT1-receptor antibodies. A year later the aorta and mesenteric artery of the immunized rats were collected to detect their structural changes. Anti-AT1-receptor antibodies purified by affinity chromatography were prepared to detect their effect on vascular smooth muscle cell (VSMC) proliferation by the method of bromodeoxyuridine incorporation and cell cycle distribution, and their effect on the expression of VSMC c-jun and c-fos mRNA by reverse transcription–polymerase chain reaction and Western blot. Anti-AT1-receptor antibodies were detected in immunized rats throughout the year without significant changes in blood pressure or heart rate, but pathological changes in the arteries were noted at the end of the study period. Purified anti-AT1-receptor antibodies improved proliferation of VSMC and upregulated c-jun expression, which were both attenuated by losartan. In summary, anti-AT1-receptor antibodies can be prepared by active immunization with the peptide of AT1 as the antigen, without changes in blood pressure or heart rate. Anti-AT1-receptor antibodies may play a role in hypertension through upregulation of c-jun expression, thus improving VSMC proliferation and finally inducing vascular recombination.
Tài liệu tham khảo
ML Fu H Herlitz G Wallukat E Hilme T Hedner J Hoebeke A Hjalmarson (1996) ArticleTitleNon-desensitized positive chronotropic effect of anti-angiotension II receptor autoantibodies in a patient with malignant hypertension (abstract Circulation 94 4046a
G Wallukat V Homuth T Fischer C Lindschau B Horstkamp A Jüpner E Baur E Nissen K Vetter D Neichel JW Dudenhausen H Haller FC Luft (1999) ArticleTitlePatients with preeclampsia develop agonistic antibodies against the angiotension AT1 receptor J Clin Invest 103 945–952
YH Liao YM Wei M Wang ZH Wang HT Yuan LX Cheng (2002) ArticleTitleAutoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension Hypertens Res 25 641–646
Fu ML, Leung PS, Wallukat G, Bergstrom G, Fu H, Schulze W, Herlitz H (1999) Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 8:317–324
ML Fu H Herlitz W Schulze G Wallukat P Micke P Eftekhari KG Sjogren A Hjalmarson W Muller-Esterl J Hoebeke (2000) ArticleTitleAutoantibodies against the angiotensin receptor (AT1) in patients with hypertension J Hypertens 18 945–953
JM Zhi LY Zhao XY Jiao RR Zhao (2002) ArticleTitleChanges in autoantibodies against cardiovascular AT1-receptor during development of renovascular hypertension in rats Sheng Li Xue Bao 54 317–320
YS Luo YH Liao M Wang YM Wei JH Dong JP Wang YP Lu (2001) ArticleTitleExpermental study of At1-receptor peptide induced myocardial immune damage in rats J Tongji Med Univ 21 202–204
J Li B Zhang Z Huang S Wang C Tang J Du (2004) ArticleTitleTaurine prevents beta-glycerophosphate-induced muscle cells Heart Vessels 19 125–131
M Rhian L Schiffrin Touyz and Ernesto (2000) ArticleTitleSignal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells Hypertension 52 639–672
H Gavras HR Brunner (2001) ArticleTitleRole of angiotensin and its inhibition in hypertension, ischemia heart disease and heart failure Hypertension 37 342
B Folkow (1995) The structural factor in hypertension, with special emphasis in the altered geometric design of the systemic JH Laragh BM Brenner (Eds) Hypertension: physiology, diagnosis, and management Raven Press New York 31